We’re excited to announce that Scantox will be exhibiting at AD/PD™ 2026, taking place this March on our home turf in Copenhagen!
The AD/PD™ conference is a globally recognized event that brings together leading medical and scientific professionals focused on advancing the understanding and treatment of Alzheimer’s, Parkinson’s, and related neurodegenerative diseases.
As a leading CRO in neuropharmacology, Scantox offers a sophisticated portfolio of validated transgenic and non-transgenic in vivo and in vitro models tailored to preclinical research in neurodegeneration. This event is a great opportunity to explore how our models and expertise can support your next preclinical project.
Visit us at booth #67 or connect with our scientists during one of our poster presentations to discuss your upcoming studies and how we can help accelerate your research.
We look forward to seeing you in Copenhagen!
